核心期刊网首页> 美国政府科技报告> AD

WTO, Intellectual Property Rights, and the Access to Medicines Controversy


In August 2003, the World Trade Organization (WTO) reached an agreement on the use of compulsory licenses by developing countries without manufacturing capacity to access life-sustaining medicines. This agreement was incorporated as an amendment to Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement on the eve of the Hong Kong Ministerial in December 2005. The issue of access to affordable medicines is one of great concern to developing countries whose health-care systems are often overwhelmed by HIV/AIDS and other infectious diseases. Some developing countries have viewed the TRIPS agreement as an impediment in their attempts to combat such public health emergencies by restricting drug availability and by transferring scarce resources from developing countries to developed country manufacturers. For the developing world, the issue of compulsory licenses is an important test as to whether the WTO can meet the development needs of its members, and conversely, whether the developing world can influence the actions of the world trading system. Developed country pharmaceutical industries view the TRIPS agreement as essential to encourage innovation in the pharmaceutical sector by assuring international compensation for their intellectual property. Without such protection, industry claims it could not recoup the high costs of developing new medicines. Producers have unilaterally undertaken to reduce prices for certain HIV/AIDS medicines, but these efforts at differential pricing have not been systematic. The United States has been forceful in defending the interest of the U.S. pharmaceutical industry in the negotiations. In December 2002, the United States blocked a compromise on the compulsory licensing issue to which all other nations had agreed; however, it was also the first nation to ratify the December 2005 amendment. In the 109th Congress, legislation was introduced (S. 3175) to establish procedures to grant compulsory licenses for exporting pa.......

【作者名称】: Fergusson, I. F.
【作者单位】: Congressional Research Service, Washington, DC.
【关 键 词】: Developing nations, Drugs, Public health, Patents, Legislation, Manufacturing
【期刊论文数据库】: [DBS_Articles_01]
【期刊论文编号】: 104,448,740
【摘要长度】: 2,001
【上篇论文】: 美国政府科技报告 - USAFA Cadet Homepage: Institute for Information Technology Applications (IITA)
【下篇论文】: 美国政府科技报告 - Design of Geopolymeric Materials Based on Nanostructural Characterization and Modeling

【论文下载】: 免费获取 该期刊&论文全文内容